Menstrual Blood-Derived Endometrial Stem Cell Transplantation Improves Male Reproductive Dysfunction in T1D Mice by Enhancing Antioxidative Capacity

© 2024. The Author(s), under exclusive licence to Society for Reproductive Investigation..

Diabetes is known to negatively affect male reproduction. Recent clinical results have confirmed that mesenchymal stem cell (MSC)-based therapies are safe and effective for the treatment of diabetes. However, the effect and potential mechanism through which MSC transplantation improves diabetes-derived male reproductive dysfunction are still unknown. In the present study, we first established a male T1D mouse model through intraperitoneal injection of streptozotocin for five consecutive days. Subsequently, we evaluated the blood glucose levels, fertility, and histology and immunology of the pancreas, testes, and penis of T1D mice with or without transplantation of menstrual blood-derived endometrial stem cells (MenSCs) or umbilical cord mesenchymal stem cells (UCMSCs). Glucose was added to the medium in which the Leydig cells were cultured to imitate high glucose-injured cell viability. Subsequently, we evaluated the cellular viability, ROS levels, and mitochondrial membrane potential of Leydig cells treated with or without MenSC-conditioned medium (MenSC-CM) using a CCK8 assay, immunofluorescence, and flow cytometry. The targeted proteins are involved in the potential mechanism underlying MenSC-derived improvements, which was further validated via Western blotting. Collectively, our results indicated that MenSC transplantation significantly ameliorated reproductive dysfunction in male T1D mice by enhancing cellular antioxidative capacity and promoting angiogenesis. This study provides solid evidence and support for the application of MSCs to improve diabetes-induced male reproductive dysfunction.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - year:2024

Enthalten in:

Reproductive sciences (Thousand Oaks, Calif.) - (2024) vom: 23. Feb.

Sprache:

Englisch

Beteiligte Personen:

Lu, Yilin [VerfasserIn]
Liu, Ruihong [VerfasserIn]
Kang, Xingpeng [VerfasserIn]
Zhang, Shenghui [VerfasserIn]
Sun, Yuliang [VerfasserIn]
Fan, Wenqiang [VerfasserIn]
Cheng, Hongbin [VerfasserIn]
Liu, Yanli [VerfasserIn]
Lin, Juntang [VerfasserIn]

Links:

Volltext

Themen:

Antioxidative capacity
Journal Article
Male reproductive dysfunction
Menstrual blood–derived endometrial stem cell
Mesenchymal stem cells
T1D

Anmerkungen:

Date Revised 24.02.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1007/s43032-024-01498-8

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36886281X